Our data suggest that the “progressive” epigenetic alterations occurred from AT1 to AR1 possibly contribute to the secondary mutations that are required for the development of leukemia in the MLL-AF9 murine model system [4], [22]. This evidence concerns the gene MLLT3 and leukemia.